CCO offentlig
[search 0]
Mer
Download the App!
show episodes
 
Artwork
 
Weekly updates on new data and best practices in patient care for a variety of infectious diseases including COVID-19, HIV, and viral hepatitis, from Clinical Care Options. Gain practical strategies and earn CME/CE credit for selected episodes.
  continue reading
 
Weekly updates on new data, current advances, and best practices in patient care for a variety of medical specialties including NASH, diabetes, muscular dystrophy, and more from Clinical Care Options. Gain practical strategies and earn CME/CE credit for selected episodes.
  continue reading
 
Artwork

1
CCOHS Podcasts

Canadian Centre for Occupational Health and Safety (CCOHS)

Unsubscribe
Unsubscribe
Månedlig
 
CCOHS produces monthly podcasts on a wide variety of topics related to workplace health and safety. Each episode is designed to keep you current with information, tips and insights into the health, safety and well-being of working Canadians. You can download the audio segment to your computer or MP3 player and listen to it at your own convenience.!
  continue reading
 
Artwork

1
CCO Neuroscience Podcast

Clinical Care Options

Unsubscribe
Unsubscribe
Månedlig
 
Updates on new data and best practices in patient care across a wide variety of psychiatric and neurological illnesses from Clinical Care Options. Gain a deeper understanding and practical clinical insights on topics ranging from bipolar depression to Parkinson’s disease psychosis. Select episodes available for CME/CE credit.
  continue reading
 
Artwork

1
The New CCO

Page Society

Unsubscribe
Unsubscribe
Månedlig
 
The New CCO podcast from Page tells stories that explore the evolution of the CCO. From culture change to digital transformation to corporate purpose, we focus on the issues that matter to today's communications leaders. Page is the world’s premier membership organization for chief communications officers, PR agency CEOs and educators who seek to enrich the profession and improve corporate reputation management.
  continue reading
 
Artwork

1
CCO Oncology Podcast

Clinical Care Options

Unsubscribe
Unsubscribe
Månedlig+
 
Updates on new data and best practices in the care of patients with cancer across a wide variety of solid tumors and hematologic malignancies from Clinical Care Options. Gain practical clinical insights and strategies and earn CME/CE credit for selected episodes.
  continue reading
 
Artwork

1
radio sindical CCOO

l'alancantí-les marines

Unsubscribe
Unsubscribe
Månedlig
 
Este programa tiene como objetivo acercar la realidad de la acción sindical a un número cada vez mayor de personas, de manera que la ciudadanía cuente con información directa y de primera mano sobre esta actividad. Se desarrollará tanto la faceta más laboral del sindicato (información sobre conflictos, convenios, salud laboral, igualdad de oportunidades, negociación colectiva, resolución de dudas laborales,...) como su papel más sociopolítico (movilización social, relación con el tejido asoc ...
  continue reading
 
Loading …
show series
 
In this episode, Tzu-Hao (Howard) Lee, MD; Tatyana Kushner, MD, MSCE; and patient advocate Andrew Reynolds discuss hepatitis C virus (HCV) care in men who have sex with men and pregnant people, including: HCV disease burden in the United States Screening recommendations Strategies to overcome barriers to HCV screening Treatment recommendations, inc…
  continue reading
 
In this episode, Sonal Kumar, MD, MPH, discusses key findings from primary biliary cholangitis (PBC) studies presented at AASLD 2024, including: ELATIVE, a phase III trial of elafibranor for PBC RESPONSE, a phase III trial of seladelpar for PBC ASSURE, another phase III trial of seladelpar for PBC Presenter: Sonal Kumar, MD, MPH Director, Clinical …
  continue reading
 
In this episode, Sonal Kumar, MD, MPH, discusses key findings from primary biliary cholangitis (PBC) studies presented at AASLD 2024, including: ELATIVE, a phase III trial of elafibranor for PBC RESPONSE, a phase III trial of seladelpar for PBC ASSURE, another phase III trial of seladelpar for PBC Presenter: Sonal Kumar, MD, MPH Director, Clinical …
  continue reading
 
Listen in as Stephen Cantrill, MD, FACEP; Rajesh T. Gandhi, MD; and Payal K. Patel, MD, MPH, FIDSA, discuss current trends in and risk factors for progression to severe COVID-19, including for those for whom COVID-19 is not their primary concern when presenting to the emergency department (ED). Key topics of discussion include: How to complete a co…
  continue reading
 
In this episode, Stacey B. Trooskin, MD, PhD, MPH, Mark S. Sulkowski, MD, FIDSA, FAASLD, and Ronni Marks discuss hepatitis C virus (HCV) screening and treatment, focusing on people who use drugs, and highlight the following topics: Screening recommendations Strategies to improve HCV screening HCV testing Treatment goals Strategies to improve HCV tr…
  continue reading
 
Listen in as Stephen Cantrill, MD, FACEP; Rajesh T. Gandhi, MD; and Payal K. Patel, MD, MPH, FIDSA, discuss best practices in treating patients hospitalized with mild to moderate COVID-19, including: Current guidelines from the Infectious Diseases Society of America and National Institutes of Health How to optimize therapy selection based on patien…
  continue reading
 
Clinical gaps in the treatment of pruritus in primary biliary cholangitis (PBC) remain. In this episode, taken from a recent symposium, Marlyn J. Mayo, MD; Stuart C. Gordon, MD; and Pam Rivard, RN, a person living with PBC, discuss emerging therapies currently in clinical trials for the management of this disease that can dramatically affect patien…
  continue reading
 
Clinical gaps in the treatment of pruritus in primary biliary cholangitis (PBC) remain. In this episode, taken from a recent symposium, Marlyn J. Mayo, MD; Stuart C. Gordon, MD; and Pam Rivard, RN, a person living with PBC, discuss emerging therapies currently in clinical trials for the management of this disease that can dramatically affect patien…
  continue reading
 
Although there is currently no FDA-approved treatment for pruritus in primary biliary cholangitis (PBC), symptoms can be mitigated with nonpharmacologic or pharmacologic agents. In this episode, Marlyn J. Mayo, MD; Stuart C. Gordon, MD; and Pam Rivard, RN, a person living with PBC, discuss the clinical management of pruritus in PBC, including: Prur…
  continue reading
 
Although there is currently no FDA-approved treatment for pruritus in primary biliary cholangitis (PBC), symptoms can be mitigated with nonpharmacologic or pharmacologic agents. In this episode, Marlyn J. Mayo, MD; Stuart C. Gordon, MD; and Pam Rivard, RN, a person living with PBC, discuss the clinical management of pruritus in PBC, including: Prur…
  continue reading
 
In this episode, Marlyn J. Mayo, MD; Stuart C. Gordon, MD; and Pam Rivard, RN, a person living with primary biliary cholangitis (PBC), discuss the burden of pruritus in PBC and the impact it has on quality of life, including both physical and mental health, from a patient’s perspective. Presenters: Marlyn J. Mayo, MD Professor of Internal Medicine …
  continue reading
 
In this episode, Marlyn J. Mayo, MD; Stuart C. Gordon, MD; and Pam Rivard, RN, a person living with primary biliary cholangitis (PBC), discuss the burden of pruritus in PBC and the impact it has on quality of life, including both physical and mental health, from a patient’s perspective. Presenters: Marlyn J. Mayo, MD Professor of Internal Medicine …
  continue reading
 
In this episode, Jean-Michel Molina, MD, PhD, and Joseph J. Eron, Jr., MD, discuss results from key clinical trials on HIV prevention and treatment as well as sexually transmitted infection (STI) prevention presented at IDWeek and Glasgow 2024, including: PURPOSE 1 and 2 comparing lenacapavir injection vs oral TDF/FTC TRIO Health Cohort and OPERA e…
  continue reading
 
In this episode, Christopher L. Bowlus, MD, discusses recent advances in the management of primary biliary cholangitis (PBC), including: Treatment goals Use of PPAR agonists for the treatment of PBC Clinical trial results for elafibranor (ELATIVE), seladelpar (RESPONSE), and bezafibrate (BEZURSO) Presenter: Christopher L. Bowlus, MD Lena Valente Pr…
  continue reading
 
In this episode, Christopher L. Bowlus, MD, discusses recent advances in the management of primary biliary cholangitis (PBC), including: Treatment goals Use of PPAR agonists for the treatment of PBC Clinical trial results for elafibranor (ELATIVE), seladelpar (RESPONSE), and bezafibrate (BEZURSO) Presenter: Christopher L. Bowlus, MD Lena Valente Pr…
  continue reading
 
In this episode, Dr Robert Cotes and Dr David Goldsmith discuss their clinical experience with long-acting injectable antipsychotic treatments in the Grady Health System, with a focus on communication strategies to educate patients on their treatment options and engage them in shared decision-making. Presenters: Robert O. Cotes, MD, DFAPA Associate…
  continue reading
 
Generative AI is evolving from a simple productivity booster to a strategic game-changer in communications. At the Page Up Annual Conference in October, member Ethan McCarty moderated a dynamic panel featuring Joao Belo of Takeda Pharmaceuticals, April Yue of Boston University, and Dan Gaynor of Signal AI. Together, they explored how to leverage AI…
  continue reading
 
La bonne tenue des locaux de travail peut sembler un concept simple, mais elle n’est pas toujours reconnue à sa juste valeur. Découvrez comment une tenue efficace des locaux peut réduire le risque de glissades, de trébuchements et de chutes, qui sont à l’origine de blessures entraînant une absence au travail parmi les plus courantes.…
  continue reading
 
In this episode, a transfemme nonbinary individual living with HIV shares her experience navigating the healthcare system, alongside her infectious disease physician, Michelle D. Collins-Ogle, MD, FAAP, FPIDS, AAHIVS. Hear them discuss key considerations when caring for gender-diverse individuals, including: Understanding how people are more than j…
  continue reading
 
Listen as Elizabeth Kircher, DNP, and R. Hal Scofield, MD, discuss best practice approaches for the treatment of Sjögren’s syndrome and what’s on the horizon for future therapeutic options. Topics include: Challenges in Sjogren’s Syndrome Diagnosis and Patient Understanding: Difficulties in explaining Sjogren’s syndrome diagnosis to patients unfami…
  continue reading
 
In this rapid webinar, Meredith E. Clement, MD, and Linda-Gail Bekker, MBChB, DTMH, DCH, FCP(SA), PhD, provide an overview of important topics and studies presented at HIVR4P 2024, including: Expanding PrEP options based on results from PURPOSE 2, IMPOWER-22, IMPOWER-24, IPM 054, MTN-025/HOPE OLE, CATALYST, and the HPTN 084 substudy Implementing in…
  continue reading
 
Listen in as Rebekah Fenton, MD, MPH, and Sharon G. Humiston, MD, MPH, discuss strategies to achieve health equity in HPV vaccination, including: Trends among males vs females Messaging considerations for those from diverse populations (eg, LGTBQ+ and rural communities) How healthcare professionals can address barriers to care Then, hear answers fr…
  continue reading
 
Listen in as Rebekah Fenton, MD, MPH, and Sharon G. Humiston, MD, MPH, discuss strategies to improve your messaging techniques with the HPV vaccine, including: Persisting in vaccine recommendation after initial refusal Educating patients and their families together Ensuring staff are trained to correctly answer questions Knowing when interested pat…
  continue reading
 
Listen in as Sharon G. Humiston, MD, MPH, discusses current trends in HPV, including: Incidence and prevalence trends in the US Sex-related features of HPV-attributable cancers How HPV vaccination uptake can prevent certain types of cancer Current guidelines and recommendations for HPV vaccination Presenter: Sharon G. Humiston, MD, MPH Director for…
  continue reading
 
Following our interview with the 2024 Page and IPR Case Study Competition winners, we bring you an extended conversation between the students and Katherine Frymark, EVP of Corporate Communications at Mattel, getting an insider perspective on the success behind Barbie’s brand transformation. The insightful conversation, led by IPR President Tina McC…
  continue reading
 
In this episode, Caitlin Costello, MD, discusses important topics related to relapsed/refractory (R/R) multiple myeloma (MM), including: 3 bispecific antibodies approved for the treatment of R/R MM that target BCMA or GPRC5D The role of bispecific antibodies in R/R MM Safety considerations for patients while receiving a bispecific antibody Emerging…
  continue reading
 
While the outcome of this unusual election cycle is uncertain, one thing is clear: CCOs will be treading carefully between two political minefields. At our recent Annual Conference, Bruce Mehlman, a renowned expert on the intersection of business, politics and technology, delivered a compelling session on the key drivers of today’s political climat…
  continue reading
 
In this episode, Thor R. Halfdanarson, MD, and Jonathan Strosberg, MD, discuss important topics related to gastroenteropancreatic neuroendocrine tumors (GEP-NETs), including: The diagnosis and typical presenting symptoms of GEP-NETs Findings from recent key phase III studies including NETTER-2 and CABINET Recommendations for treatment sequencing No…
  continue reading
 
When it came out, Barbie dominated the box office, grossing nearly $1.5 billion at the box office. But what many don't realize is the movie was part of a larger strategy, to reposition the iconic doll in the minds of consumers. The Grand Prize Winners of the 2024 Page and IPR Case Study Competition focused on how Mattel managed this effort, and wha…
  continue reading
 
In this episode, Kathleen Page, MD, and Glenn J. Treisman, MD, PhD, discuss the interplay between addiction and HIV. Learn as they share their approaches to reframing the conversation about addiction and overcoming barriers to effective addiction care for people living with HIV. Presenters: Kathleen Page, MD Professor Infectious Diseases Johns Hopk…
  continue reading
 
In this episode, listen to Ana Oaknin, MD, PhD and Alexandra Leary, MD, PhD, share their clinical insights and takeaways on key updates and new data presented for ovarian, endometrial, and cervical cancer at the ESMO 2024 annual congress including: Phase III PRIMA/ENGOT-OV26/GOG-3012 Final OS Results: Niraparib as First-Line Maintenance in Advanced…
  continue reading
 
In this episode, listen to Matthew S. Davids, MD, MMSc​, and Lindsey Roeker, MD, discuss BTK inhibitor resistance and how it shapes treatment choices for patients with CLL, including: Contemporary treatment paradigms for patients with CLL Safety and efficacy of current regimens Molecular testing, including when and how to test for BTK inhibitor res…
  continue reading
 
In this episode, Alexander Wong, MD, FRCPC, discusses how to optimize treatment and engagement in care for individuals with HIV and substance use disorder, including: Barriers to care for persons with substance use disorder Colocating HIV and other services (eg, addiction care medicine, social services) Leveraging a multidisciplinary approach to ca…
  continue reading
 
Farms experiencing a surge in bird flu infections can put people who work with poultry and dairy cattle at risk of catching the illness. In this episode, we talk with CCOHS Senior Technical Specialist Matea Kokorovic about measures you can take to protect your workers. Released: September 13, 2024 File Size: 2.5 MB Length: 5:01 minutes…
  continue reading
 
Les exploitations qui connaissent une recrudescence des infections par la grippe aviaire exposent les personnes qui travaillent avec les volailles et les bovins laitiers au risque de contracter la maladie. Au cours du présent épisode, nous nous entretenons avec Matea Kokorovic, spécialiste technique principale du Centre canadien d’hygiène et de séc…
  continue reading
 
In this CCO Nephrology podcast episode, hear from nephrologists Pietro Canetta, MD, MS, and Andy Bomback, MD, PhD, experts in clinical management and research on glomerular diseases as they discuss key updates in managing IgAN. Faculty highlight the importance of a comprehensive supportive care regimen to protect patients’ kidneys and prevent progr…
  continue reading
 
In this episode, listen to Alice T. Shaw, MD, PhD, and Jessica J. Lin, MD, share their thoughts on the available and emerging clinical data for second-line and beyond treatments in patients with recurrent ROS1-altered advanced NSCLC including: Assessing ROS1-TKI resistance mutations with tumor and liquid biopsies in patients with ROS1-altered advan…
  continue reading
 
In this episode, listen to Alice T. Shaw, MD, PhD, and Jessica J. Lin, MD, share their thoughts on the available clinical data in support of frontline treatments for ROS1-altered NSCLC including: Efficacy and safety data for crizotinib, entrectinib, and repotrectinib in patients with ROS1-altered advanced NSCLC Long-term safety observations for cri…
  continue reading
 
In this episode, Jennifer Cocohoba, PharmD, AAHIVP, and David Koren, PharmD, MPH, AAHIVP, FIDSA, cover the most impactful LA ART and LA PrEP clinical studies presented at AIDS 2024, including: The PURPOSE 1 study of twice-yearly lenacapavir injections vs daily oral tenofovir as PrEP in cisgender women An open-label extension of HPTN 084 evaluating …
  continue reading
 
In this episode, listen to Alice T. Shaw, MD, PhD, and Jessica J. Lin, MD, share their thoughts on the current understanding of ROS1 rearrangements in non-small-cell lung cancer tumor biology and its implications for molecular testing and treatment selection including: ROS1-gene fusions in advanced lung cancer ROS1 testing recommendations with DNA …
  continue reading
 
In this episode, Tristan J. Barber, MA, MD, FRCP, and Glenn J. Treisman, MD, PhD, discuss the importance of screening, diagnosing, and treating PTSD in people with HIV. They illustrate their discussion through a patient case and provide strategies for accomplishing this, sharing their own experiences and approaches to thinking about PTSD, structuri…
  continue reading
 
In this CCO Nephrology podcast episode, hear from cardiologist Erin D. Michos, MD, MHS, FACC, FAHA, FASE, FASPC, and nephrologist Mark J. Sarnak, MD, MS, as they discuss new and emerging therapies designed to target residual inflammatory risk associated with ASCVD and CKD.    Episode outline:   Colchicine: inhibition of NLRP3 inflammasome assembly/…
  continue reading
 
Loading …

Hurtigreferanseguide

Copyright 2025 | Sitemap | Personvern | Vilkår for bruk | | opphavsrett
Lytt til dette showet mens du utforsker
Spill